Formation Bio is a biotechnology company that leverages artificial intelligence and technology to streamline the drug development process. The company aims to address the inefficiencies in clinical trials, which are a major bottleneck in bringing new treatments to patients. By integrating expertise from both the tech and pharmaceutical industries, Formation Bio seeks to accelerate the creation and approval of new drugs, making treatments more accessible and reducing healthcare costs.

Formation Bio

Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.

We are excited to announce our collaboration with OpenAI and Sanofi to build fine-tuned and custom AI solutions to transform drug development. Since our inception, we have focused on building a pharma company differentiated by radical efficiency throughout drug development and clinical trials - and this collaboration helps us advance that vision. 
 
As AI accelerates drug discovery, generating more promising candidate drugs than ever before, we believe the most consequential bottleneck to bringing more medicines to patients is the staggering cost and time needed for drug development and clinical trials. By designing and developing AI specifically tailored for drug development, we can increase the total number of candidate drugs that can progress through development, and ultimately deliver more new treatments to patients faster and more efficiently.

You can read more about the collaboration here: https://lnkd.in/eYx9_QYg
#ai #drugdevelopment #clinicaltrials #pharma #biotech

Formation Bio will be attending PharmaSUG 2024! Our team members Helena Belloff Melanie Hullings Andrew Burd Emily Murphy Laura Fazio, MS will be presenting on May 20th and 21st - we hope to see you there! Details below. 

#software #datascience #pharma #biotech #conference #baltimore #statisticalprogramming #research #clinicaldevelopment #PharmaSUG2024

We have had an exciting Q1 at Formation Bio! We are thrilled to introduce our newest team members Amanda Hyler, Jamie C., Marianne Hawes, Joseph St.Amand, Gina DiGello, Benjamin Miles, Debra Wallace, and Jennifer Kang.

In honor of Women's Heritage Month, the Women's Employee Resource Group at Formation Bio - a tech-driven drug development company - is hosting a virtual event for young women interested in learning more about pursuing STEM fields on March 20th at 5 PM EST . We hope to inspire and empower young women by providing them with insights and guidance opportunities from successful women professionals at our organization. If you're interested in attending, please fill out this form so we can send you the Zoom links! #womensupportingwomen  #equality  #stem 

Sign up - https://lnkd.in/eVxmfe3D

msh id	BIO:FORMATION
symbol	-
name	Formation Bio
homepage url	https://formation.bio
country	US
sector	Healthcare & Health Services
industry	Biotechnology
market	PRIVATE
employee count	167
crunchbase url	https://www.crunchbase.com/organization/formation-bio
linkedin url	https://www.linkedin.com/company/formationbio
founders	-

market cap	-
enterprise value	-
stage	-
raised capital	-
valuation	-

monthly webtraffic	-
monthly webtraffic growth	-
growth score 14	-
growth score 28	-
growth score 90	-
growth score 365	-

revenue ltm	-
gross profit ltm	-
ebitda ltm	-
net income ltm	-
revenue ntm	-
gross profit ntm	-
ebitda ntm	-
net income ntm	-

growth cost and expenses	-
growth cost of revenue	-
growth depreciation and amortization	-
growth ebitda	-
growth ebitda ratio	-
growth eps	-
growth eps diluted	-
growth general and administrative expenses	-
growth gross profit	-
growth gross profit ratio	-

BIO:FORMATION

Formation Bio

Company Information

Market Metrics

Web & Growth Metrics

LTM & NTM Metrics

Growth & Performance Metrics

Operating Metrics

Balance Sheet Metrics

Financial Metrics (2022-2026)

cost and expenses	-
cost of revenue	-
depreciation and amortization	-
ebitda	-
ebitda ratio	-
eps	-
eps diluted	-
operating expenses	-
operating income	-
operating income ratio	-

accounts receivables	-
capital expenditure	-
cash at beginning of period	-
cash at end of period	-
inventory	-
working capital ttm	-

	2022	2023	2024	2025	2026
Revenue Metrics
Revenue	-	-	-	-	-
Revenue Growth	-	-	-	-	-
Revenue Multiple	-	-	-	-	-
Profit Metrics
Gross Profit	-	-	-	-	-
Gross Profit Growth	-	-	-	-	-
Gross Profit Multiple	-	-	-	-	-
EBITDA Metrics
EBITDA	-	-	-	-	-
EBITDA Growth	-	-	-	-	-
EBITDA Multiple	-	-	-	-	-
Net Income Metrics
Net Income	-	-	-	-	-
Net Income Growth	-	-	-	-	-
Net Income Multiple	-	-	-	-	-